Godrej Agrovet Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 20, 2025, 10:38 pm

Quick Insight

Godrej Agrovet Ltd, a prominent player in the animal/shrimp feed industry, currently trades at a price of 786 with a market capitalization of 15,133 crore. The company's P/E stands at 36.0, with a healthy ROE and ROCE of 16.6%. Operating profit margin is at 7%, and net profit amounts to 403 crore. With promoters holding a significant stake of 74.03%, institutional investors and public shareholders account for 9.48% and 12.14%, respectively. The company's strong reserves of 2,189 crore provide a solid financial base, although borrowings stand at 1,396 crore. Notably, the Price-to-Book Value ratio is 3.72x, and the Interest Coverage Ratio is 6.89x, indicating a sound financial position. Investors should consider the company's robust fundamentals and market positioning for long-term potential in the animal feed sector.

Competitors of Godrej Agrovet Ltd

All Competitor Stocks of Godrej Agrovet Ltd

Quarterly Result

Last Updated: August 20, 2025, 10:15 am

Below is a detailed analysis of the quarterly data for Godrej Agrovet Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 2,614.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,134.00 Cr. (Mar 2025) to 2,614.00 Cr., marking an increase of 480.00 Cr..
• For Expenses, as of Jun 2025, the value is 2,345.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,987.00 Cr. (Mar 2025) to 2,345.00 Cr., marking an increase of 358.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 270.00 Cr.. The value appears strong and on an upward trend. It has increased from 147.00 Cr. (Mar 2025) to 270.00 Cr., marking an increase of 123.00 Cr..
• For OPM %, as of Jun 2025, the value is 10.00%. The value appears strong and on an upward trend. It has increased from 7.00% (Mar 2025) to 10.00%, marking an increase of 3.00%.
• For Other Income, as of Jun 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 25.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 35.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 29.00 Cr. (Mar 2025) to 35.00 Cr., marking an increase of 6.00 Cr..
• For Depreciation, as of Jun 2025, the value is 58.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 56.00 Cr. (Mar 2025) to 58.00 Cr., marking an increase of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 200.00 Cr.. The value appears strong and on an upward trend. It has increased from 87.00 Cr. (Mar 2025) to 200.00 Cr., marking an increase of 113.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 26.00%, marking an increase of 2.00%.
• For Net Profit, as of Jun 2025, the value is 149.00 Cr.. The value appears strong and on an upward trend. It has increased from 66.00 Cr. (Mar 2025) to 149.00 Cr., marking an increase of 83.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 8.35. The value appears strong and on an upward trend. It has increased from 3.68 (Mar 2025) to 8.35, marking an increase of 4.67.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:47 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 3:10 pm

Below is a detailed analysis of the balance sheet data for Godrej Agrovet Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 192.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 192.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,189.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,324.00 Cr. (Mar 2024) to 2,189.00 Cr., marking a decrease of 135.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,396.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1,416.00 Cr. (Mar 2024) to 1,396.00 Cr., marking a decrease of 20.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,729.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,734.00 Cr. (Mar 2024) to 1,729.00 Cr., marking a decrease of 5.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 5,505.00 Cr.. The value appears to be improving (decreasing). It has decreased from 5,667.00 Cr. (Mar 2024) to 5,505.00 Cr., marking a decrease of 162.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 2,912.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,806.00 Cr. (Mar 2024) to 2,912.00 Cr., marking an increase of 106.00 Cr..
• For CWIP, as of Mar 2025, the value is 64.00 Cr.. The value appears to be declining and may need further review. It has decreased from 192.00 Cr. (Mar 2024) to 64.00 Cr., marking a decrease of 128.00 Cr..
• For Investments, as of Mar 2025, the value is 139.00 Cr.. The value appears to be declining and may need further review. It has decreased from 177.00 Cr. (Mar 2024) to 139.00 Cr., marking a decrease of 38.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,391.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,492.00 Cr. (Mar 2024) to 2,391.00 Cr., marking a decrease of 101.00 Cr..
• For Total Assets, as of Mar 2025, the value is 5,505.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,667.00 Cr. (Mar 2024) to 5,505.00 Cr., marking a decrease of 162.00 Cr..

Notably, the Reserves (2,189.00 Cr.) exceed the Borrowings (1,396.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Godrej Agrovet Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 18.71. This value is within the healthy range. It has increased from 15.71 (Mar 23) to 18.71, marking an increase of 3.00.
• For Diluted EPS (Rs.), as of Mar 24, the value is 18.71. This value is within the healthy range. It has increased from 15.71 (Mar 23) to 18.71, marking an increase of 3.00.
• For Cash EPS (Rs.), as of Mar 24, the value is 27.14. This value is within the healthy range. It has increased from 23.36 (Mar 23) to 27.14, marking an increase of 3.78.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 151.97. It has increased from 142.78 (Mar 23) to 151.97, marking an increase of 9.19.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 151.97. It has increased from 142.78 (Mar 23) to 151.97, marking an increase of 9.19.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 497.40. It has increased from 487.81 (Mar 23) to 497.40, marking an increase of 9.59.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 38.64. This value is within the healthy range. It has increased from 32.80 (Mar 23) to 38.64, marking an increase of 5.84.
• For PBIT / Share (Rs.), as of Mar 24, the value is 27.49. This value is within the healthy range. It has increased from 23.15 (Mar 23) to 27.49, marking an increase of 4.34.
• For PBT / Share (Rs.), as of Mar 24, the value is 21.88. This value is within the healthy range. It has increased from 17.99 (Mar 23) to 21.88, marking an increase of 3.89.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 15.99. This value is within the healthy range. It has increased from 13.71 (Mar 23) to 15.99, marking an increase of 2.28.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 18.71. This value is within the healthy range. It has increased from 15.71 (Mar 23) to 18.71, marking an increase of 3.00.
• For PBDIT Margin (%), as of Mar 24, the value is 7.76. This value is below the healthy minimum of 10. It has increased from 6.72 (Mar 23) to 7.76, marking an increase of 1.04.
• For PBIT Margin (%), as of Mar 24, the value is 5.52. This value is below the healthy minimum of 10. It has increased from 4.74 (Mar 23) to 5.52, marking an increase of 0.78.
• For PBT Margin (%), as of Mar 24, the value is 4.39. This value is below the healthy minimum of 10. It has increased from 3.68 (Mar 23) to 4.39, marking an increase of 0.71.
• For Net Profit Margin (%), as of Mar 24, the value is 3.21. This value is below the healthy minimum of 5. It has increased from 2.80 (Mar 23) to 3.21, marking an increase of 0.41.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 3.76. This value is below the healthy minimum of 8. It has increased from 3.22 (Mar 23) to 3.76, marking an increase of 0.54.
• For Return on Networth / Equity (%), as of Mar 24, the value is 14.29. This value is below the healthy minimum of 15. It has increased from 12.91 (Mar 23) to 14.29, marking an increase of 1.38.
• For Return on Capital Employeed (%), as of Mar 24, the value is 15.05. This value is within the healthy range. It has increased from 14.31 (Mar 23) to 15.05, marking an increase of 0.74.
• For Return On Assets (%), as of Mar 24, the value is 6.30. This value is within the healthy range. It has increased from 5.50 (Mar 23) to 6.30, marking an increase of 0.80.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.11. This value is below the healthy minimum of 0.2. It has increased from 0.02 (Mar 23) to 0.11, marking an increase of 0.09.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.51. This value is within the healthy range. It has decreased from 0.56 (Mar 23) to 0.51, marking a decrease of 0.05.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.71. It has increased from 1.69 (Mar 23) to 1.71, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 24, the value is 1.04. This value is below the healthy minimum of 1.5. It has increased from 0.96 (Mar 23) to 1.04, marking an increase of 0.08.
• For Quick Ratio (X), as of Mar 24, the value is 0.37. This value is below the healthy minimum of 1. It has increased from 0.36 (Mar 23) to 0.37, marking an increase of 0.01.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 4.90. This value is within the healthy range. It has decreased from 4.91 (Mar 23) to 4.90, marking a decrease of 0.01.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 50.76. This value exceeds the healthy maximum of 50. It has decreased from 60.46 (Mar 23) to 50.76, marking a decrease of 9.70.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 31.81. This value is within the healthy range. It has decreased from 37.45 (Mar 23) to 31.81, marking a decrease of 5.64.
• For Earning Retention Ratio (%), as of Mar 24, the value is 49.24. This value is within the healthy range. It has increased from 39.54 (Mar 23) to 49.24, marking an increase of 9.70.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 68.19. This value is within the healthy range. It has increased from 62.55 (Mar 23) to 68.19, marking an increase of 5.64.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 6.89. This value is within the healthy range. It has increased from 6.36 (Mar 23) to 6.89, marking an increase of 0.53.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 3.85. This value is within the healthy range. It has increased from 3.66 (Mar 23) to 3.85, marking an increase of 0.19.
• For Enterprise Value (Cr.), as of Mar 24, the value is 11,014.00. It has increased from 9,629.43 (Mar 23) to 11,014.00, marking an increase of 1,384.57.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.15. This value is within the healthy range. It has increased from 1.03 (Mar 23) to 1.15, marking an increase of 0.12.
• For EV / EBITDA (X), as of Mar 24, the value is 14.83. This value is within the healthy range. It has decreased from 15.28 (Mar 23) to 14.83, marking a decrease of 0.45.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.97. This value is below the healthy minimum of 1. It has increased from 0.84 (Mar 23) to 0.97, marking an increase of 0.13.
• For Retention Ratios (%), as of Mar 24, the value is 49.23. This value is within the healthy range. It has increased from 39.53 (Mar 23) to 49.23, marking an increase of 9.70.
• For Price / BV (X), as of Mar 24, the value is 3.72. This value exceeds the healthy maximum of 3. It has increased from 3.39 (Mar 23) to 3.72, marking an increase of 0.33.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.97. This value is below the healthy minimum of 1. It has increased from 0.84 (Mar 23) to 0.97, marking an increase of 0.13.
• For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness